The detection of ctDNA is usually achieved through advanced techniques such as Next-Generation Sequencing (NGS) and digital PCR. These methods are sensitive enough to identify the low levels of ctDNA present in the bloodstream. The process involves isolating cfDNA from a blood sample, followed by the amplification and sequencing of specific genetic markers associated with cancer.
